Cancer genomics

Cancer Genomics

Cancer genomics is the study of the totality of DNA sequence and gene expression differences between tumor cells and normal host cells. It involves the application of genomic sequencing technologies to a field of oncology to improve the diagnosis and treatment of cancer.

Pronunciation

Can-cer Ge-no-mics

Etymology

The term "Cancer genomics" is derived from the Latin word "cancer" meaning "crab" and the Greek word "genomikos" meaning "pertaining to genes".

Related Terms

• Genomics: The study of the genomes of organisms.
• Oncology: The study and treatment of tumors.
• Tumor: An abnormal growth of tissue resulting from uncontrolled, progressive multiplication of cells and serving no physiological function.
• DNA sequencing: The process of determining the precise order of nucleotides within a DNA molecule.
• Gene expression: The process by which information from a gene is used in the synthesis of a functional gene product.

Overview

Cancer genomics is a rapidly evolving field that has been made possible by advances in genomic sequencing technologies. It aims to identify the genetic changes that drive the development and progression of cancer, with the ultimate goal of improving the diagnosis and treatment of this disease.

Cancer genomics studies have revealed that each tumor has a unique set of genetic alterations, some of which may be targeted by specific therapies. This has led to the development of precision medicine, an approach to patient care that allows doctors to select treatments that are most likely to help patients based on a genetic understanding of their disease.

Applications

Cancer genomics has numerous applications in oncology, including:

• Identifying new biomarkers that can be used to diagnose cancer at an early stage.
• Discovering new drug targets for the development of targeted therapies.
• Predicting patient response to treatment based on their tumor's genetic profile.
• Understanding the mechanisms of drug resistance in cancer cells.

Challenges

Despite its potential, cancer genomics also faces several challenges. These include the complexity of the cancer genome, the difficulty of distinguishing driver mutations from passenger mutations, and the need for large-scale, collaborative efforts to fully realize the potential of this approach.

This WikiMD.org article is a stub. You can help make it a full article.